206 related articles for article (PubMed ID: 7539029)
1. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer.
Strieter RM; Polverini PJ; Arenberg DA; Walz A; Opdenakker G; Van Damme J; Kunkel SL
J Leukoc Biol; 1995 May; 57(5):752-62. PubMed ID: 7539029
[TBL] [Abstract][Full Text] [Related]
2. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
[TBL] [Abstract][Full Text] [Related]
3. CXC chemokines in angiogenesis.
Belperio JA; Keane MP; Arenberg DA; Addison CL; Ehlert JE; Burdick MD; Strieter RM
J Leukoc Biol; 2000 Jul; 68(1):1-8. PubMed ID: 10914483
[TBL] [Abstract][Full Text] [Related]
4. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer.
Arenberg DA; Polverini PJ; Kunkel SL; Shanafelt A; Hesselgesser J; Horuk R; Strieter RM
J Leukoc Biol; 1997 Nov; 62(5):554-62. PubMed ID: 9365108
[TBL] [Abstract][Full Text] [Related]
5. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM
J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086
[TBL] [Abstract][Full Text] [Related]
6. Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10).
Arenberg DA; White ES; Burdick MD; Strom SR; Strieter RM
Cancer Immunol Immunother; 2001 Dec; 50(10):533-8. PubMed ID: 11776375
[TBL] [Abstract][Full Text] [Related]
7. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.
Numasaki M; Watanabe M; Suzuki T; Takahashi H; Nakamura A; McAllister F; Hishinuma T; Goto J; Lotze MT; Kolls JK; Sasaki H
J Immunol; 2005 Nov; 175(9):6177-89. PubMed ID: 16237115
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.
Arenberg DA; Kunkel SL; Polverini PJ; Morris SB; Burdick MD; Glass MC; Taub DT; Iannettoni MD; Whyte RI; Strieter RM
J Exp Med; 1996 Sep; 184(3):981-92. PubMed ID: 9064358
[TBL] [Abstract][Full Text] [Related]
9. The role of CXC chemokines as regulators of angiogenesis.
Strieter RM; Polverini PJ; Arenberg DA; Kunkel SL
Shock; 1995 Sep; 4(3):155-60. PubMed ID: 8574748
[TBL] [Abstract][Full Text] [Related]
10. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis.
Strieter RM; Kunkel SL; Arenberg DA; Burdick MD; Polverini PJ
Biochem Biophys Res Commun; 1995 May; 210(1):51-7. PubMed ID: 7537965
[TBL] [Abstract][Full Text] [Related]
11. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
12. CXC chemokines in angiogenesis relevant to chronic fibroproliferation.
Strieter RM; Belperio JA; Burdick MD; Keane MP
Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):23-6. PubMed ID: 15720231
[TBL] [Abstract][Full Text] [Related]
13. CXC chemokines in angiogenesis of cancer.
Strieter RM; Belperio JA; Phillips RJ; Keane MP
Semin Cancer Biol; 2004 Jun; 14(3):195-200. PubMed ID: 15246055
[TBL] [Abstract][Full Text] [Related]
14. Cancer CXC chemokine networks and tumour angiogenesis.
Strieter RM; Burdick MD; Mestas J; Gomperts B; Keane MP; Belperio JA
Eur J Cancer; 2006 Apr; 42(6):768-78. PubMed ID: 16510280
[TBL] [Abstract][Full Text] [Related]
15. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis.
Keane MP; Arenberg DA; Lynch JP; Whyte RI; Iannettoni MD; Burdick MD; Wilke CA; Morris SB; Glass MC; DiGiovine B; Kunkel SL; Strieter RM
J Immunol; 1997 Aug; 159(3):1437-43. PubMed ID: 9233641
[TBL] [Abstract][Full Text] [Related]
16. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.
Strieter RM; Polverini PJ; Kunkel SL; Arenberg DA; Burdick MD; Kasper J; Dzuiba J; Van Damme J; Walz A; Marriott D
J Biol Chem; 1995 Nov; 270(45):27348-57. PubMed ID: 7592998
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis.
Addison CL; Belperio JA; Burdick MD; Strieter RM
BMC Cancer; 2004 Jun; 4():28. PubMed ID: 15214968
[TBL] [Abstract][Full Text] [Related]
18. Chemokines: angiogenesis and metastases in lung cancer.
Strieter RM; Belperio JA; Phillips RJ; Keane MP
Novartis Found Symp; 2004; 256():173-84; discussion 184-8, 259-69. PubMed ID: 15027490
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.
White ES; Flaherty KR; Carskadon S; Brant A; Iannettoni MD; Yee J; Orringer MB; Arenberg DA
Clin Cancer Res; 2003 Feb; 9(2):853-60. PubMed ID: 12576459
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.
Arenberg DA; Keane MP; DiGiovine B; Kunkel SL; Morris SB; Xue YY; Burdick MD; Glass MC; Iannettoni MD; Strieter RM
J Clin Invest; 1998 Aug; 102(3):465-72. PubMed ID: 9691082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
